| Literature DB >> 30987383 |
John F Dou1, Zishaan Farooqui2,3, Christopher D Faulk4, Amanda K Barks5, Tamara Jones6, Dana C Dolinoy7,8, Kelly M Bakulski9.
Abstract
: Lead (Pb) exposure is associated with a wide range of neurological deficits. Environmental exposures may impact epigenetic changes, such as DNA methylation, and can affect neurodevelopmental outcomes over the life-course. Mating mice were obtained from a genetically invariant C57BL/6J background agouti viable yellow Avy strain. Virgin dams (a/a) were randomly assigned 0 ppm (control), 2.1 ppm (low), or 32 ppm (high) Pb-acetate water two weeks prior to mating with male mice (Avy/a), and this continued through weaning. At age 10 months, cortex neuronal nuclei were separated with NeuN⁺ antibodies in male mice to investigate neuron-specific genome-wide promoter DNA methylation using the Roche NimbleGen Mouse 3x720K CpG Island Promoter Array in nine pooled samples (three per dose). Several probes reached p-value < 10-5 , all of which were hypomethylated: 12 for high Pb (minimum false discovery rate (FDR) = 0.16, largest intensity ratio difference = -2.1) and 7 for low Pb (minimum FDR = 0.56, largest intensity ratio difference = -2.2). Consistent with previous results in bulk tissue, we observed a weak association between early-life exposure to Pb and DNA hypomethylation, with some affected genes related to neurodevelopment or cognitive function. Although these analyses were limited to males, data indicate that non-dividing cells such as neurons can be carriers of long-term epigenetic changes induced in development.Entities:
Keywords: DNA methylation; Pb; in utero; lead; neuron
Mesh:
Substances:
Year: 2019 PMID: 30987383 PMCID: PMC6523909 DOI: 10.3390/genes10040274
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.141
Figure 1Differentially methylated regions associated with high perinatal Pb exposure (32 ppm) relative to controls. Top hits reaching Stouffer <0.5. Regions within dashed lines indicate the differentially methylated region. The area outside the boundary are plotted to show trends outside the region. Nearest gene to regions: (A) Predicted pseudogene 7609 (Gm7609), chromosome 1:85268190-85268860. (B) RIKEN cDNA D130017N08 gene (D130017N08Rik), chromosome 5:144518792-144519402. (C) Artemin (Artn), chromosome 4:117599180-117599790. (D) Zinc finger protein 974 (Zfp974), chromosome 7:28716109-28717334. (E) Predicted gene 2012 (Gm2012), chromosome X:25736758-25738103. (F) Complement component 5a receptor 1 (C5ar1), chromosome 7:16846702-16847382.
Figure 2Differentially methylated regions associated with low perinatal Pb exposure (2.1 ppm) relative to controls. Regions within dashed lines indicate the differentially methylated region. Areas outside boundary are plotted to show the trend outside the region. Nearest gene to regions: (A) G protein-coupled receptor 20 (Gpr20), chromosome 15:73526358-73526668. (B) Predicted gene 10471 (Gm10471), chromosome 5:26397335-26397645. (C) Zinc finger protein 787 (Xfp787), chromosome 7:6083700-6084000. (D) X-linked Kx blood group related 7 (Xkr7), chromosome 2:152880160-152880455. (E) Ankyrin repeat and death domain containing 1B (Ankdd1b), chromosome 13:97240389-97240694. (F) Cadherin-like 24 (Cdh24), chromosome 14:55251097-55251412.
Figure 3Differentially methylated regions overlapping between high (32 ppm) and low perinatal Pb exposure. Regions within dashed lines indicate the differentially methylated region. Areas outside the boundary are plotted to show the trend outside the region. Nearest gene to regions: (A) Paired-Ig-like receptor A1 (Pira1), chromosome 7: 3850945-3851730. (B) Single-strand selective monofunctional uracil DNA glycosylase (Smug1), chromosome 7:31611349-31611731. (C) Free fatty acid receptor 2 (Ffar2), chromosome 15:102977038-102977683.
Top gene ontologies enriched among differentially methylated genes associated with high perinatal Pb exposure (32 ppm) relative to control treated mice.
| GO Term ID | Pathway | Adjusted | Enrichment Score | Normalized Enrichment Score | Number of Permutations More Extreme | Size of Pathway | |
|---|---|---|---|---|---|---|---|
| GO:0010165 | response to X-ray | 0.002 | 1 | 0.9 | 1.69 | 1 | 16 |
| GO:0043206 | fibril organization | 0.0044 | 1 | 0.94 | 1.66 | 3 | 7 |
| GO:0015693 | magnesium ion transport | 0.0052 | 1 | 0.91 | 1.68 | 4 | 11 |
| GO:0014912 | negative regulation of smooth muscle cell migration | 0.0065 | 1 | 0.92 | 1.63 | 5 | 8 |
| GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity | 0.0069 | 1 | 0.96 | 1.64 | 5 | 5 |
| GO:0046887 | positive regulation of hormone secretion | 0.0071 | 1 | 0.87 | 1.64 | 6 | 14 |
| GO:0051798 | positive regulation of hair follicle development | 0.0073 | 1 | −0.69 | −1.66 | 0 | 5 |
| GO:0046545 | development of primary female sexual characteristics | 0.0073 | 1 | −0.78 | −1.88 | 0 | 5 |
| GO:0045542 | positive regulation of cholesterol biosynthetic process | 0.0073 | 1 | −0.68 | −1.64 | 0 | 5 |
| GO:0032471 | reduction of endoplasmic reticulum calcium ion concentration | 0.0073 | 1 | −0.75 | −1.81 | 0 | 5 |
| GO:0050930 | induction of positive chemotaxis | 0.0074 | 1 | 0.91 | 1.65 | 6 | 10 |
| GO:0010667 | negative regulation of cardiac muscle cell apoptotic process | 0.0074 | 1 | 0.91 | 1.63 | 6 | 9 |
| GO:0071396 | cellular response to lipid | 0.0076 | 1 | 0.92 | 1.63 | 6 | 7 |
| GO:0000186 | activation of Mitogen-activated protein kinase kinase activity | 0.009 | 1 | 0.84 | 1.6 | 8 | 23 |
| GO:0001841 | neural tube formation | 0.0091 | 1 | 0.86 | 1.63 | 8 | 15 |
Top gene ontologies enriched among differentially methylated genes associated with low perinatal Pb exposure (2.1 ppm) relative to control treated mice.
| GO Term ID | Pathway | Adjusted | Enrichment Score | Normalized Enrichment Score | Number of Permutations More Extreme | Size of Pathway | |
|---|---|---|---|---|---|---|---|
| GO:0007565 | female pregnancy | 0.001 | 0.97 | 0.58 | 1.51 | 0 | 56 |
| GO:0006334 | nucleosome assembly | 0.001 | 0.97 | 0.59 | 1.56 | 0 | 85 |
| GO:0042100 | B cell proliferation | 0.001 | 0.97 | 0.86 | 1.95 | 0 | 12 |
| GO:0007218 | neuropeptide signaling pathway | 0.002 | 1 | 0.55 | 1.45 | 1 | 80 |
| GO:0055003 | cardiac myofibril assembly | 0.0022 | 1 | 0.83 | 1.81 | 1 | 9 |
| GO:0007379 | segment specification | 0.0024 | 1 | 0.91 | 1.75 | 1 | 5 |
| GO:0055088 | lipid homeostasis | 0.0032 | 1 | 0.81 | 1.76 | 2 | 9 |
| GO:0035567 | non-canonical Wnt receptor signaling pathway | 0.0032 | 1 | 0.83 | 1.8 | 2 | 9 |
| GO:0006729 | tetrahydrobiopterin biosynthetic process | 0.0035 | 1 | 0.87 | 1.73 | 2 | 6 |
| GO:0034695 | response to prostaglandin E stimulus | 0.0044 | 1 | 0.84 | 1.79 | 3 | 8 |
| GO:0006105 | succinate metabolic process | 0.0044 | 1 | 0.84 | 1.78 | 3 | 8 |
| GO:0044255 | cellular lipid metabolic process | 0.0045 | 1 | 0.86 | 1.78 | 3 | 7 |
| GO:0060754 | positive regulation of mast cell chemotaxis | 0.0048 | 1 | 0.91 | 1.73 | 3 | 5 |
| GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 0.006 | 1 | 0.9 | 1.71 | 4 | 5 |
| GO:0019538 | protein metabolic process | 0.0075 | 1 | 0.77 | 1.69 | 6 | 10 |
| GO:0002237 | response to molecule of bacterial origin | 0.0075 | 1 | 0.77 | 1.68 | 6 | 10 |
| GO:0016051 | carbohydrate biosynthetic process | 0.0077 | 1 | 0.79 | 1.68 | 6 | 8 |
| GO:0000186 | activation of Mitogen-activated protein kinase kinase activity | 0.008 | 1 | 0.66 | 1.62 | 7 | 23 |
| GO:0042168 | heme metabolic process | 0.0094 | 1 | 0.85 | 1.69 | 7 | 6 |